Geode Capital Management, LLC Karyopharm Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,355,392 shares of KPTI stock, worth $867,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,355,392
Previous 1,311,536 3.34%
Holding current value
$867,450
Previous $1.14 Million 1.49%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$0.7 - $1.06 $30,699 - $46,487
43,856 Added 3.34%
1,355,392 $1.12 Million
Q2 2024

Aug 09, 2024
SELL
$0.87 - $1.58 $1.05 Million - $1.91 Million
-1,208,569 Reduced 47.96%
1,311,536 $1.14 Million
Q1 2024

May 13, 2024
BUY
$0.72 - $1.66 $99,127 - $228,543
137,677 Added 5.78%
2,520,105 $3.81 Million
Q4 2023

Feb 13, 2024
BUY
$0.68 - $1.31 $64,791 - $124,819
95,282 Added 4.17%
2,382,428 $2.05 Million
Q3 2023

Nov 13, 2023
BUY
$1.14 - $1.81 $171,059 - $271,594
150,052 Added 7.02%
2,287,146 $3.06 Million
Q2 2023

Aug 11, 2023
BUY
$1.79 - $4.59 $653,996 - $1.68 Million
365,361 Added 20.62%
2,137,094 $3.83 Million
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $1.12 Million - $1.55 Million
394,605 Added 28.65%
1,771,733 $6.89 Million
Q4 2022

Feb 13, 2023
BUY
$2.48 - $5.93 $115,798 - $276,889
46,693 Added 3.51%
1,377,128 $4.68 Million
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $16,793 - $23,955
4,116 Added 0.31%
1,330,435 $7.26 Million
Q2 2022

Aug 12, 2022
SELL
$4.15 - $8.37 $48,011 - $96,832
-11,569 Reduced 0.86%
1,326,319 $5.98 Million
Q1 2022

May 13, 2022
SELL
$5.91 - $14.38 $619,622 - $1.51 Million
-104,843 Reduced 7.27%
1,337,888 $9.86 Million
Q4 2021

Feb 11, 2022
BUY
$5.21 - $8.61 $185,340 - $306,292
35,574 Added 2.53%
1,442,731 $9.28 Million
Q3 2021

Nov 12, 2021
BUY
$4.45 - $10.63 $942,861 - $2.25 Million
211,879 Added 17.73%
1,407,157 $8.19 Million
Q2 2021

Aug 13, 2021
BUY
$8.11 - $11.11 $393,845 - $539,534
48,563 Added 4.23%
1,195,278 $12.3 Million
Q1 2021

May 12, 2021
BUY
$9.85 - $17.69 $1.05 Million - $1.89 Million
106,868 Added 10.28%
1,146,715 $12.1 Million
Q4 2020

Feb 12, 2021
SELL
$14.15 - $17.19 $219,155 - $266,238
-15,488 Reduced 1.47%
1,039,847 $16.1 Million
Q3 2020

Nov 13, 2020
BUY
$14.14 - $19.71 $321,586 - $448,264
22,743 Added 2.2%
1,055,335 $15.4 Million
Q2 2020

Aug 13, 2020
BUY
$16.6 - $25.25 $1.65 Million - $2.51 Million
99,265 Added 10.64%
1,032,592 $19.6 Million
Q1 2020

May 14, 2020
BUY
$14.38 - $27.72 $1.53 Million - $2.95 Million
106,355 Added 12.86%
933,327 $17.9 Million
Q4 2019

Feb 13, 2020
BUY
$9.23 - $19.67 $360,828 - $768,959
39,093 Added 4.96%
826,972 $15.9 Million
Q3 2019

Nov 12, 2019
BUY
$5.66 - $11.85 $91,556 - $191,685
16,176 Added 2.1%
787,879 $7.58 Million
Q2 2019

Aug 14, 2019
BUY
$4.32 - $6.43 $799,390 - $1.19 Million
185,044 Added 31.54%
771,703 $4.62 Million
Q1 2019

May 14, 2019
BUY
$4.12 - $10.25 $118,375 - $294,503
28,732 Added 5.15%
586,659 $3.43 Million
Q4 2018

Feb 13, 2019
BUY
$8.2 - $16.95 $216,135 - $446,768
26,358 Added 4.96%
557,927 $5.23 Million
Q3 2018

Nov 13, 2018
BUY
$17.03 - $21.18 $272,020 - $338,308
15,973 Added 3.1%
531,569 $9.05 Million
Q2 2018

Aug 14, 2018
BUY
$12.0 - $19.88 $2.33 Million - $3.86 Million
194,273 Added 60.46%
515,596 $8.76 Million
Q1 2018

May 15, 2018
BUY
$9.92 - $17.25 $403,872 - $702,299
40,713 Added 14.51%
321,323 $4.31 Million
Q4 2017

Feb 13, 2018
BUY
$9.15 - $11.99 $141,724 - $185,713
15,489 Added 5.84%
280,610 $2.69 Million
Q3 2017

Nov 14, 2017
BUY
$8.15 - $11.16 $38,321 - $52,474
4,702 Added 1.81%
265,121 $2.91 Million
Q2 2017

Aug 14, 2017
BUY
N/A
260,419
260,419 $2.36 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email